Persistent Cardiac Magnetic Resonance Imaging Findings in a Cohort of Adolescents with Post-Coronavirus Disease 2019 mRNA Vaccine Myopericarditis

Jenna Schauer; Sujatha Buddhe; Avanti Gulhane; Eyal Sagiv; Matthew Studer; Jessica Colyer; Sathish Mallenahalli Chikkabyrappa; Yuk Law; Michael A Portman

doi:10.1016/j.jpeds.2022.03.032

Persistent Cardiac Magnetic Resonance Imaging Findings in a Cohort of Adolescents with Post-Coronavirus Disease 2019 mRNA Vaccine Myopericarditis

J Pediatr. 2022 Jun:245:233-237. doi: 10.1016/j.jpeds.2022.03.032. Epub 2022 Mar 26.

Authors

Jenna Schauer¹, Sujatha Buddhe², Avanti Gulhane³, Eyal Sagiv², Matthew Studer², Jessica Colyer², Sathish Mallenahalli Chikkabyrappa², Yuk Law², Michael A Portman²

Affiliations

¹ Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA. Electronic address: Jenna.Schauer@seattlechildrens.org.
² Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA.
³ Department of Radiology, University of Washington, Seattle, WA.

Abstract

We describe the evolution of cardiac magnetic resonance imaging findings in 16 patients, aged 12-17 years, with myopericarditis after the second dose of the Pfizer mRNA coronavirus disease 2019 vaccine. Although all patients showed rapid clinical improvement, many had persistent cardiac magnetic resonance imaging findings at 3- to 8-month follow-up.

Published by Elsevier Inc.

Publication types

Case Reports

MeSH terms

Adolescent
COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Humans
Magnetic Resonance Imaging
Myocarditis* / diagnostic imaging
Myocarditis* / etiology
Pericarditis* / diagnostic imaging
Pericarditis* / etiology
RNA, Messenger
Vaccines, Synthetic
mRNA Vaccines

Substances

COVID-19 Vaccines
RNA, Messenger
Vaccines, Synthetic
mRNA Vaccines